Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Neem Research Group
mi
from
Columbia, SC
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Neem Research Group
mi
from
Columbia, SC
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Mountain View Clinical Research
mi
from
Greer, SC
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Mountain View Clinical Research
mi
from
Greer, SC
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Medical clinic of North Texas
mi
from
Arlington, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Medical clinic of North Texas
mi
from
Arlington, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Renaissance Clinical Research
mi
from
Dallas, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Renaissance Clinical Research
mi
from
Dallas, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Dallas Diabetes and Endocrine Center
mi
from
Dallas, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
T&R Clinic
mi
from
Fort Worth, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
T&R Clinic
mi
from
Fort Worth, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
MedStar Clinical Research Associates
mi
from
Houston, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
MedStar Clinical Research Associates
mi
from
Houston, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Heights Doctors Clinic
mi
from
Houston, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Heights Doctors Clinic
mi
from
Houston, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Allegiant Clinical Research
mi
from
Houston, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Allegiant Clinical Research
mi
from
Houston, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Juno Research
mi
from
Houston, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Juno Research
mi
from
Houston, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
dgdResearch Inc
mi
from
San Antonio, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
dgdResearch Inc
mi
from
San Antonio, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Cetero Research
mi
from
Fargo, ND
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Cetero Research
mi
from
Fargo, ND
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Innovative Clinical Trials
mi
from
San Antonio, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Innovative Clinical Trials
mi
from
San Antonio, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Clinical Health Research
mi
from
Sugar Land, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Clinical Health Research
mi
from
Sugar Land, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Martin Diagnostic Center
mi
from
Tomball, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Martin Diagnostic Center
mi
from
Tomball, TX
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Optimum Clinical Research
mi
from
Salt Lake City, UT
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Optimum Clinical Research
mi
from
Salt Lake City, UT
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Wasatch Clinical Research
mi
from
Salt Lake City, UT
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Wasatch Clinical Research
mi
from
Salt Lake City, UT
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Manassas Clinical Research Center
mi
from
Manassas, VA
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Manassas Clinical Research Center
mi
from
Manassas, VA
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Salem VA Medical Center
mi
from
Salem, VA
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Salem VA Medical Center
mi
from
Salem, VA
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Aurora Advanced Healthcare
mi
from
Milwaukee, WI
Welchol as Monotherapy for Type 2 Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Welchol as Monotherapy for Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Aurora Advanced Healthcare
mi
from
Milwaukee, WI
Timing of Insulin Before Meals Everyday
The Importance of Insulin Timing in Type 1 Diabetes
Status: Archived
University of New Mexico
mi
from
Albuquerque, NM
Timing of Insulin Before Meals Everyday
The Importance of Insulin Timing in Type 1 Diabetes
Status: Archived
Updated: 1/1/1970
University of New Mexico
mi
from
Albuquerque, NM
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Birmingham, AL
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Birmingham, AL
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Center for Fertility and Women's Health
mi
from
New Britain, CT
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Center for Fertility and Women's Health
mi
from
New Britain, CT
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Aurora, CO
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Aurora, CO
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Hartford, CT
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Hartford, CT
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Washington,
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Washington,
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Abington Memorial Hospital
mi
from
Abington, PA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Abington Memorial Hospital
mi
from
Abington, PA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Atlanta, GA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Atlanta, GA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Veterans Affairs Medical Center, Washington D.C.
mi
from
Washington D.C.,
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center, Washington D.C.
mi
from
Washington D.C.,
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Oak Lawn, IL
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Oak Lawn, IL
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Inova Fairfax
mi
from
Falls Church, VA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Inova Fairfax
mi
from
Falls Church, VA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Kansas City, KA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kansas City, KA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
New Orleans, LA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
New Orleans, LA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Springfield, MA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Springfield, MA
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Detroit, MI
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Detroit, MI
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Bloomington, MN
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bloomington, MN
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Kansas City, MO
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Kansas City, MO
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Missoula, MT
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Missoula, MT
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Omaha, NE
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Omaha, NE
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Las Vegas, NV
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Las Vegas, NV
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Camden, NJ
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Camden, NJ
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Albuquerque,, NM
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Albuquerque,, NM
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
New York, NY
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
New York, NY
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Asheville, NC
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Asheville, NC
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Bismarck, ND
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bismarck, ND
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Clinical Research Facility
mi
from
Columbus, OH
Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Columbus, OH